← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2016Last known activity
Oct 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Indications
Recent trials (4)
- NCT05562232Lead sponsorN/AOct 1, 2022
- NCT05562232Reponsible party - principal investigatorN/AOct 1, 2022
- NCT02451293Study chairPhase 2/Phase 3Jan 1, 2016
- NCT02451293CollaboratorPhase 2/Phase 3Jan 1, 2016
Details
- Last known activity
- Oct 1, 2022